tiprankstipranks
Xbrane Biopharma AB (SE:XBRANE)
:XBRANE
Sweden Market
Want to see SE:XBRANE full AI Analyst Report?

Xbrane Biopharma AB (XBRANE) Technical Analysis

10 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
1Neutral
7Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
5Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Xbrane Biopharma AB’s (XBRANE) Moving Averages Convergence Divergence (MACD) indicator is 0.62, suggesting Xbrane Biopharma AB is a Sell.
Xbrane Biopharma AB’s (XBRANE) 20-Day exponential moving average is 7.58, while Xbrane Biopharma AB’s (XBRANE) share price is kr10.37, making it a Buy.
Xbrane Biopharma AB’s (XBRANE) 50-Day exponential moving average is 7.88, while Xbrane Biopharma AB’s (XBRANE) share price is kr10.37, making it a Buy.

Xbrane Biopharma AB (XBRANE) Pivot Points

May 01, 2026, 02:48 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.08
7.44
7.86
8.22
8.64
9.00
9.42
Fibonacci
7.44
7.74
7.92
8.22
8.52
8.70
9.00
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Xbrane Biopharma AB (XBRANE) Moving Averages

May 01, 2026, 02:48 AM
Period
Simple
Exponential
MA5
8.87Buy
9.19Buy
MA10
8.00Buy
8.31Buy
MA20
7.03Buy
7.58Buy
MA50
7.43Buy
7.88Buy
MA100
8.96Buy
10.36Buy
MA200
18.60Sell
17.51Sell
Xbrane Biopharma AB’s (XBRANE) 10-Day exponential moving average is 8.31, while Xbrane Biopharma AB’s (XBRANE) share price is kr10.37, making it a Buy.
Xbrane Biopharma AB’s (XBRANE) 100-Day exponential moving average is 10.36, while Xbrane Biopharma AB’s (XBRANE) share price is kr10.37, making it a Buy.
Xbrane Biopharma AB’s (XBRANE) stock price is kr10.37 and Xbrane Biopharma AB’s (XBRANE) 50-day simple moving average is 7.43, creating a Buy signal.
Xbrane Biopharma AB’s (XBRANE) stock price is kr10.37 and Xbrane Biopharma AB’s (XBRANE) 100-day simple moving average is 8.96, creating a Buy signal.
Xbrane Biopharma AB’s (XBRANE) stock price is kr10.37 and Xbrane Biopharma AB’s (XBRANE) 200-day simple moving average is 18.60, creating a Sell signal.

Xbrane Biopharma AB (XBRANE) Technical Indicators

May 01, 2026, 02:48 AM
Name
Value
Implied Action
RSI (14)
86.38
Sell
STOCH (9,6)
92.04
Sell
STOCHRSI (14)
93.86
Sell
MACD (12,26)
0.62
Sell
ADX (14)
33.37
Neutral
Williams %R
0.00
Sell
CCI (14)
256.39
Sell
ATR (14)
0.79
-
Ultimate Oscillator
80.98
Buy
ROC
91.67
Buy
Xbrane Biopharma AB’s (XBRANE) Relative Strength Index (RSI) is 86.38, creating a Sell signal.
Xbrane Biopharma AB’s (XBRANE) Trend Strength Indicator (ADX) is 33.37, creating a Neutral signal.
Xbrane Biopharma AB’s (XBRANE) Commodity Channel Index (CCI) is 256.39, creating a Sell signal.
Xbrane Biopharma AB’s (XBRANE) Price Rate of Change (ROC) is 91.67, creating a Buy signal.

FAQ

Is XBRANE a Buy, Hold, or Sell?
Based on XBRANE’s technical indicators, XBRANE is a Buy.
    What is XBRANE’s RSI (14)?
    XBRANE’s RSI (14) is 86.38, which suggests XBRANE is a Sell.
      What is XBRANE’s MACD?
      XBRANE’s MACD is 0.62, which suggests XBRANE is a Sell.
        What is XBRANE’s 5-day moving average?
        XBRANE’s 5-day moving average is 8.87, which suggests XBRANE is a Buy.
          What is XBRANE’s 20-day moving average?
          XBRANE 20-day moving average is 7.03, which suggests XBRANE is a Buy.
            What is XBRANE’s 50-day moving average?
            XBRANE’s 50-day moving average is 7.43, which suggests XBRANE is a Buy.
              What is XBRANE’s 200-day moving average?
              XBRANE’s 200-day moving average is 18.60, which suggests XBRANE is a Sell.
                What is XBRANE’s Williams % R (14)?
                XBRANE’s Williams % R (14) is 0.00, which suggests XBRANE is a Sell.
                  What is XBRANE’s CCI (14)?
                  XBRANE’s CCI (14) is 256.39, which suggests XBRANE is a Sell.
                    What is the share price of Xbrane Biopharma AB?